Vasoactive intestinal peptide relaxes isolated strips of human bronchus, pulmonary artery, and lung parenchyma
- PMID: 6535346
Vasoactive intestinal peptide relaxes isolated strips of human bronchus, pulmonary artery, and lung parenchyma
Abstract
VIP, an endogenous neuropeptide normally present in lungs and other organs, relaxes isolated strips of human bronchus, pulmonary artery, and lung parenchyma in vitro. Pretreatment of these tissues with indomethacin (1 micrograms/ml) markedly enhances the basal tone and the relaxant effect of VIP. The VIP-induced relaxation, especially of pulmonary artery, has a long duration. As a relaxant of human pulmonary arterial strip, VIP is approximately 200 times as potent as prostacyclin, on a molar basis. The results suggest a possible role for VIP as a modulator of airway and pulmonary vascular tone, and as a potential bronchodilator and pulmonary vasodilator in human subjects.
Similar articles
-
Involvement of endothelial NO in the dilator effect of VIP on rat isolated pulmonary artery.Regul Pept. 2007 Mar 1;139(1-3):102-8. doi: 10.1016/j.regpep.2006.10.012. Epub 2006 Dec 14. Regul Pept. 2007. PMID: 17174416
-
Protease inhibitors potentiate smooth muscle relaxation induced by vasoactive intestinal peptide in isolated human bronchi.Am J Respir Cell Mol Biol. 1990 May;2(5):449-52. doi: 10.1165/ajrcmb/2.5.449. Am J Respir Cell Mol Biol. 1990. PMID: 2187492
-
Effects of alpha calcitonin gene-related peptide in human bronchial smooth muscle and pulmonary artery.Regul Pept. 2004 May 15;118(3):127-34. doi: 10.1016/j.regpep.2003.11.006. Regul Pept. 2004. PMID: 15003828
-
Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors.Eur J Pharmacol. 2006 Mar 8;533(1-3):182-94. doi: 10.1016/j.ejphar.2005.12.055. Epub 2006 Feb 10. Eur J Pharmacol. 2006. PMID: 16473346 Review.
-
PACAPs-potential for bronchodilation.Pulm Pharmacol Ther. 1999;12(4):229-36. doi: 10.1006/pupt.1999.0209. Pulm Pharmacol Ther. 1999. PMID: 10500002 Review. No abstract available.
Cited by
-
VIP antagonists enhance excitatory cholinergic neurotransmission in the human airway.Lung. 1994;172(3):159-67. doi: 10.1007/BF00175944. Lung. 1994. PMID: 8201830
-
NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease.PLoS One. 2017 Jan 26;12(1):e0170606. doi: 10.1371/journal.pone.0170606. eCollection 2017. PLoS One. 2017. PMID: 28125639 Free PMC article.
-
Gene Deletion of VIP Leads to Increased Mortality Associated with Progressive Right Ventricular Hypertrophy.J Cardiovasc Dis. 2014 Apr 1;2(3):131-136. J Cardiovasc Dis. 2014. PMID: 24860842 Free PMC article.
-
Emerging biologics for the treatment of pulmonary arterial hypertension.J Drug Target. 2023 Jun;31(5):1-15. doi: 10.1080/1061186X.2023.2199351. Epub 2023 Apr 26. J Drug Target. 2023. PMID: 37026714 Free PMC article. Review.
-
Peptidase modulation of vasoactive intestinal peptide pulmonary relaxation in tracheal superfused guinea pig lungs.J Clin Invest. 1993 Jan;91(1):235-43. doi: 10.1172/JCI116176. J Clin Invest. 1993. PMID: 7678603 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials